Insmed Inc INSM

NAS: INSM | ISIN: US4576693075 17/05/2024

24,77 USD (-1,31%)

(-1,31%) 17/05/2024

Grafiek Insmed Inc

Grafiek Insmed Inc

1 dag1d -1,31%
1 week1w -4,10%
1 maand1m 2,74%
3 maanden3m -15,20%
6 maanden6m 0,61%
1 jaar1j 21,96%
5 jaar5j -11,76%

Insmed Inc in het nieuws

Toon enkel gratis nieuws

9 mei 2024 · Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update · Persbericht

7 mei 2024 · Insmed To Present at the BofA Securities Health Care Conference 2024 · Persbericht

3 mei 2024 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

25 april 2024 · Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 · Persbericht

5 april 2024 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

27 maart 2024 · Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference · Persbericht

5 maart 2024 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

29 februari 2024 · Insmed To Present at Three March Conferences · Persbericht

28 februari 2024 · Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health · Persbericht

22 februari 2024 · Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update · Persbericht

Profiel Insmed Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.insmed.com

Hoofdzetel: Bridgewater, New Jersey Verenigde Staten

CEO: William Lewis

Werknemers: 778

Aandelen Insmed Inc

Beurswaarde: 3,68 miljard USD

Effecten: 148,60 miljoen

Winst per aandeel (12 maand): PLUS

Beta: 0,81

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe